Pulmonary Embolism as an Initial Presentation of Adrenocortical Carcinoma

por Aung, Soe Yu, Parente, Phillip, McKendrick, Joseph
Publicado en World J Oncol (2014)

A case of autosplenectomy associated with T-cell checkpoint inhibitor treatment

por Delahunty, Rachel, Lee, Margaret, Datta, Mineesh, Parente, Phillip
Publicado en BMJ Case Rep (2017)

SUN-487 Incidence and Natural History of Hypophysitis Secondary to Check-Point Inhibitor Therapy at a Tertiary Center

por Lafontaine Bedecarratz, Nicole, Ye, Sylvia, Parente, Phillip, Gilfillan, Christopher
Publicado en J Endocr Soc (2019)

Docetaxel in very elderly men with metastatic castration-resistant prostate cancer

por Wong, Hui-Li, Lok, Sheau Wen, Wong, Shirley, Parente, Phillip, Rosenthal, Mark
Publicado en Prostate Int (2015)

Towards new models of cancer care in Australia: lessons from Victoria's response to the COVID‐19 pandemic

por Underhill, Craig, Parente, Phillip, McArthur, Grant, Haydon, Andrew, McLachlan, Sue‐Anne, Wong, Zee Wan, Segelov, Eva
Publicado en Intern Med J (2020)

Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy

por Prithviraj, Prashanth, McArthur, Grant, Atkinson, Victoria, Parente, Phillip, Andrews, Miles, Parakh, Sagun, Millward, Michael, Cebon, Jonathan, Klein, Oliver
Publicado en J Immunother Cancer (2015)

Migrant Health in Cancer: Outcome Disparities and the Determinant Role of Migrant-Specific Variables

por Sze, Ming, Butow, Phyllis, Bell, Melanie, Vaccaro, Lisa, Dong, Skye, Eisenbruch, Maurice, Jefford, Michael, Girgis, Afaf, King, Madeleine, McGrane, Joshua, Ng, Weng, Asghari, Ray, Parente, Phillip, Liauw, Winston, Goldstein, David
Publicado en Oncologist (2015)

Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study

por Lee, Dae Ho, Isobe, Hiroshi, Wirtz, Hubert, Aleixo, Sabina Bandeira, Parente, Phillip, de Marinis, Filippo, Huang, Min, Arunachalam, Ashwini, Kothari, Smita, Cao, Xiting, Donnini, Nello, Woodgate, Ann-Marie, de Castro, Javier
Publicado en BMC Health Serv Res (2018)

Reply to ‘Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''

por Bowyer, Samantha, Prithviraj, Prashanth, Lorigan, Paul, Larkin, James, McArthur, Grant, Atkinson, Victoria, Millward, Michael, Khou, Muoi, Diem, Stefan, Ramanujam, Sangeetha, Kong, Ben, Liniker, Elizabeth, Guminski, Alexander, Parente, Phillip, Andrews, Miles C, Parakh, Sagun, Cebon, Jonathan, Long, Georgina V, Carlino, Matteo S, Klein, Oliver
Publicado en Br J Cancer (2017)

Outcomes of a randomized controlled trial assessing a smartphone Application to reduce unmet needs among people diagnosed with CancEr (ACE)

por Livingston, Patricia M., Heckel, Leila, Orellana, Liliana, Ashley, David, Ugalde, Anna, Botti, Mari, Pitson, Graham, Woollett, Anne, Chambers, Suzanne K., Parente, Phillip, Chirgwin, Jacqueline, Mihalopoulos, Cathrine, Lavelle, Barbara, Sutton, Jennifer, Phipps‐Nelson, Jo, Krishnasamy, Mei, Simons, Katherine, Heynsbergh, Natalie, Wickramasinghe, Nilmini, White, Vicki
Publicado en Cancer Med (2019)

Immunodominant CD4(+) responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant

por Chen, Qiyuan, Jackson, Heather, Parente, Phillip, Luke, Tina, Rizkalla, Mark, Tai, Tsin Yee, Zhu, He-Cheng, Mifsud, Nicole A., Dimopoulos, Nektaria, Masterman, Kelly-Anne, Hopkins, Wendie, Goldie, Heather, Maraskovsky, Eugene, Green, Simon, Miloradovic, Lena, McCluskey, James, Old, Lloyd J., Davis, Ian D., Cebon, Jonathan, Chen, Weisan
Publicado 2004

Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy

por Cmero, Marek, Kurganovs, Natalie J., Stuchbery, Ryan, McCoy, Patrick, Grima, Corrina, Ngyuen, Anne, Chow, Ken, Mangiola, Stefano, Macintyre, Geoff, Howard, Nicholas, Kerger, Michael, Dundee, Philip, Ruljancich, Paul, Clarke, David, Grummet, Jeremy, Peters, Justin S., Costello, Anthony J., Norden, Sam, Ryan, Andrew, Parente, Phillip, Hovens, Christopher M., Corcoran, Niall M.
Publicado en JCO Precis Oncol (2021)

Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors

por Desai, Jayesh, Gan, Hui, Barrow, Catherine, Jameson, Michael, Atkinson, Victoria, Haydon, Andrew, Millward, Michael, Begbie, Stephen, Brown, Michael, Markman, Ben, Patterson, William, Hill, Andrew, Horvath, Lisa, Nagrial, Adnan, Richardson, Gary, Jackson, Christopher, Friedlander, Michael, Parente, Phillip, Tran, Ben, Wang, Lai, Chen, Yunxin, Tang, Zhiyu, Huang, Wendy, Wu, John, Zeng, Dewan, Luo, Lusong, Solomon, Benjamin
Publicado en J Clin Oncol (2020)

Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer

por Kwan, Edmond M., Fettke, Heidi, Crumbaker, Megan, Docanto, Maria M., To, Sarah Q., Bukczynska, Patricia, Mant, Andrew, Ng, Nicole, Foroughi, Siavash, Graham, Lisa-Jane K., Haynes, Anne-Maree, Azer, Sarah, Lim, Lisi Elizabeth, Segelov, Eva, Mahon, Kate, Davis, Ian D., Parente, Phillip, Pezaro, Carmel, Todenhöfer, Tilman, Sathianathen, Niranjan, Hauser, Christine, Horvath, Lisa G., Joshua, Anthony M., Azad, Arun A.
Publicado en Transl Androl Urol (2021)

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

por Davis, Ian D., Chen, Weisan, Jackson, Heather, Parente, Phillip, Shackleton, Mark, Hopkins, Wendie, Chen, Qiyuan, Dimopoulos, Nektaria, Luke, Tina, Murphy, Roger, Scott, Andrew M., Maraskovsky, Eugene, McArthur, Grant, MacGregor, Duncan, Sturrock, Sue, Tai, Tsin Yee, Green, Simon, Cuthbertson, Andrew, Maher, Darryl, Miloradovic, Lena, Mitchell, Susan V., Ritter, Gerd, Jungbluth, Achim A., Chen, Yao-Tseng, Gnjatic, Sacha, Hoffman, Eric W., Old, Lloyd J., Cebon, Jonathan S.
Publicado 2004